Selecting treatment options in refractory metastatic colorectal cancer

Survival of patients with metastatic colorectal cancer (mCRC) has significantly improved in the last decade. Survival gains are not driven by advances in first-line therapy but by incremental additional effects of subsequent treatment lines. To maximize outcomes, patients should receive all active a...

Descripción completa

Detalles Bibliográficos
Autores principales: Byrne, Margaret, Saif, Muhammad Wasif
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6441549/
https://www.ncbi.nlm.nih.gov/pubmed/30988631
http://dx.doi.org/10.2147/OTT.S194605

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6441549/
https://www.ncbi.nlm.nih.gov/pubmed/30988631
http://dx.doi.org/10.2147/OTT.S194605

Ejemplares similares